5.53
前日終値:
$6.34
開ける:
$5.65
24時間の取引高:
146.37K
Relative Volume:
0.07
時価総額:
$8.62M
収益:
$8.62M
当期純損益:
$-6.15M
株価収益率:
-0.5014
EPS:
-11.03
ネットキャッシュフロー:
$-5.32M
1週間 パフォーマンス:
+8.01%
1か月 パフォーマンス:
+25.97%
6か月 パフォーマンス:
+9.07%
1年 パフォーマンス:
+24.83%
Evoke Pharma Inc Stock (EVOK) Company Profile
EVOK を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EVOK
Evoke Pharma Inc
|
5.53 | 8.90M | 8.62M | -6.15M | -5.32M | -11.03 |
![]()
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2020-06-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
2019-03-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2018-03-08 | 繰り返されました | B. Riley FBR, Inc. | Buy |
2017-10-19 | 再開されました | FBR & Co. | Buy |
2017-03-16 | 繰り返されました | Rodman & Renshaw | Buy |
2017-01-30 | アップグレード | Laidlaw | Neutral → Buy |
2017-01-05 | アップグレード | Rodman & Renshaw | Neutral → Buy |
2016-12-23 | 繰り返されました | Rodman & Renshaw | Neutral |
2016-07-19 | 繰り返されました | FBR Capital | Outperform |
2016-07-19 | ダウングレード | Noble Financial | Buy → Hold |
2016-07-18 | ダウングレード | Rodman & Renshaw | Buy → Neutral |
2016-03-16 | 開始されました | Northland Capital | Outperform |
2016-03-14 | 繰り返されました | Ascendiant Capital Markets | Buy |
2016-02-17 | 再開されました | FBR Capital | Outperform |
2014-12-03 | 繰り返されました | MLV & Co | Buy |
2014-11-07 | 開始されました | MLV & Co | Buy |
2014-04-22 | 開始されました | Laidlaw | Buy |
2013-11-19 | 開始されました | Aegis Capital | Buy |
すべてを表示
Evoke Pharma Inc (EVOK) 最新ニュース
Evoke Pharma Inc. Ranks High in Smart Money TrackerVolume Spike & Weekly Breakout Opportunity Watchlist - classian.co.kr
Can Evoke Pharma Inc. rally from current levelsMarket Risk Report & Real-Time Volume Analysis - Newser
How to build a dashboard for Evoke Pharma Inc. stock2025 Major Catalysts & High Yield Equity Trading Tips - Newser
Can Evoke Pharma Inc. recover in the next quarterJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Technical signs of recovery in Evoke Pharma Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - Newser
What machine learning models say about Evoke Pharma Inc.July 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
Chart based analysis of Evoke Pharma Inc. trendsDip Buying & Advanced Swing Trade Entry Alerts - Newser
Investors Still Aren't Entirely Convinced By Evoke Pharma, Inc.'s (NASDAQ:EVOK) Revenues Despite 31% Price Jump - simplywall.st
Applying Elliott Wave Theory to Evoke Pharma Inc.July 2025 Big Picture & Weekly Top Gainers Alerts - Newser
Evoke Pharma Inc. Sees Relief Buying After Extended DropJuly 2025 Summary & Community Verified Swing Trade Signals - Newser
Momentum divergence signals in Evoke Pharma Inc. chartEarnings Recap Report & Accurate Technical Buy Alerts - Newser
Evoke Pharma Earnings Miss: Revenue Falls Short, Earnings Plunge to -$2.69 EPS Amid Rising Costs - AInvest
Using data filters to optimize entry into Evoke Pharma Inc.2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Evoke Pharma Reports Q2 2025 Earnings: Loss Widens Despite Revenue Gains; Market Reaction Remains Cautious - AInvest
Backtesting results for Evoke Pharma Inc. trading strategiesTrade Entry Report & Weekly Chart Analysis and Guides - Newser
Is Evoke Pharma Inc. forming a breakout patternQuarterly Profit Review & Daily Profit Focused Stock Screening - newsyoung.net
Evoke Pharma sees FY25 net product sales of approx $16M - MSN
Evoke Pharma Inc. stock trendline breakdownJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsEntry Point & Free Community Consensus Stock Picks - Newser
Can a trend reversal in Evoke Pharma Inc. lead to recovery2025 Pullback Review & Expert Approved Momentum Ideas - Newser
Using RSI to spot recovery in Evoke Pharma Inc.July 2025 Decliners & Verified Momentum Stock Ideas - Newser
Evoke Pharma Reports 47% Q2 2025 Sales Growth, Raises Full-Year Guidance - AInvest
Evoke Pharma reports Q2 EPS (62c) vs (93c) last year - MSN
How sentiment analysis helps forecast Evoke Pharma Inc.Weekly Trade Analysis & Growth Oriented Trading Recommendations - Newser
Top Risks to Consider Before Buying Evoke Pharma Inc. StockTake Profit & Weekly Watchlist of Top Performers - Newser
Evoke Pharma Posts 47 Percent Q2 Growth - AOL.com
Evoke Pharma Inc. Builds Base for Possible Rebound2025 Major Catalysts & Real-Time Market Sentiment Alerts - kangso.co.kr
Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Decreases By 78.2% - Defense World
Evoke Pharma Reports Strong Q2 2025 Sales Growth - TipRanks
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Evoke Pharma 2025 Q2 Earnings Mixed Performance with Net Loss Widening - AInvest
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.2025 Breakouts & Breakdowns & Long-Term Growth Stock Strategies - newsyoung.net
Evoke Pharma Reports 47% Q2 Growth, Affirms FY Sales Outlook - AInvest
Evoke Pharma Q2 Earnings: Revenue at $3.75M, EPS of 62c - AInvest
RSI Reset May Fuel Rebound in Evoke Pharma Inc.Weekly Market Report & Smart Allocation Stock Reports - beatles.ru
Evoke Pharma, Inc. Confirms Sales Guidance for the Year 2025 - MarketScreener
Evoke Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Evoke Pharma Inc SEC 10-Q Report - TradingView
Gastroparesis Drug Maker Evoke Posts Strong Growth as GIMOTI Adoption Accelerates - Stock Titan
Is Evoke Pharma Inc. trending in predictive chart modelsJuly 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Will Volume Confirm Reversal in Evoke Pharma Inc.July 2025 Market Mood & Fast Gain Stock Trading Tips - sundaytimes.kr
Evoke Pharma Inc (EVOK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):